MedPath

QARZIBA 4,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

QARZIBA 4,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1171191001

Prescription Type

Uso Hospitalario

Authorization Date

Sep 6, 2018

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1171191001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

DINUTUXIMAB BETAActive
Quantity: 4,5 mg
Name: DINUTUXIMAB BETA

ATC CLASSIFICATION (3)

L01F
L01FX
L01FX06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.